Physicians
Patients
Knowledge Center
News
About Us
More
HeartLung Receives FDA “Breakthrough” Designation and Marketing Authorization for the First AI to Enable Opportunistic Detection of Hidden Heart Disease in Millions of CT Scans
HeartLung's distinguished advisor, Dr. Claudia Henschke, who pioneered lung cancer screening, wins the RSNA 2024 Scientific Excellence Award 🏆⚕️
HeartLung Technologies to Present Four Scientific Research Studies on AI-CAC™, AutoBMD™, and AI-CVD™ at the 2024 Radiological Society of North America (RSNA 2024)
HeartLung Technologies Presented AI-CAC™ and AI-CVD™ Research Studies at the Annual Scientific Sessions of the American Heart Association 2024
HeartLung Technologies Receives FDA “Breakthrough” Designation and Marketing Authorization for AutoChamber™
Seven Groundbreaking AI-Enabled Research Studies to be Presented at the Annual Congress of the European Society of Cardiology 2024 in London